← Leaderboards
Mark Dybul
Niaid Extramural Activities
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Niaid Extramural Activities
Same institution · by research overlap
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsHuman Therapy EvaluationAntiaids AgentAids TherapyHuman SubjectCombination ChemotherapyClinical TrialsLongitudinal Human StudyPatient Oriented ResearchDrug Administration Rate /DurationTissue /Cell CultureClinical ResearchHost Organism InteractionImmune Tolerance /UnresponsivenessAfricaAntiviral AgentsPolymerase Chain ReactionT LymphocyteInterleukin 2Human Immunodeficiency Virus 1Virus LoadVirus ReceptorsAidsB Lymphocyte
Grant awards (7)
Antiretroviral Treatment Interruption as a Long-term The$0
Z01 · FY2004 · AI
Antiretroviral Treatment Interruption As A Long-term The$0
Z01 · FY2003 · AI
Antiretroviral Treatment Interruption As A Long-term The$0
Z01 · FY2002 · AI
Therapeutic Studies In Recently Acquired Hiv Infection$0
Z01 · FY2002 · AI
Role Of B Lymphocytes In Hiv Infection And Pathogenesis$0
Z01 · FY2002 · AI
Therapeutic Studies in Recently Acquired HIV Infection$0
Z01 · FY2000 · AI
ANTIRETROVIRAL TREATMENT INTERRUPTION AS A THERAPEUTIC$0
Z01 · FY2000 · AI